CAPUCCI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 8.169
EU - Europa 4.845
AS - Asia 3.540
SA - Sud America 927
AF - Africa 341
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
Totale 17.845
Nazione #
US - Stati Uniti d'America 8.028
RU - Federazione Russa 1.384
SG - Singapore 1.169
VN - Vietnam 838
BR - Brasile 732
UA - Ucraina 678
IT - Italia 596
CN - Cina 529
DE - Germania 440
IE - Irlanda 400
SE - Svezia 299
FR - Francia 257
HK - Hong Kong 245
DK - Danimarca 220
TR - Turchia 197
GB - Regno Unito 186
FI - Finlandia 178
MA - Marocco 150
KR - Corea 119
IN - India 102
CI - Costa d'Avorio 99
BD - Bangladesh 80
AR - Argentina 67
CA - Canada 62
NL - Olanda 48
MX - Messico 47
IQ - Iraq 40
JP - Giappone 38
ZA - Sudafrica 35
EC - Ecuador 33
ES - Italia 31
PL - Polonia 31
CO - Colombia 26
ID - Indonesia 25
PK - Pakistan 24
VE - Venezuela 20
AT - Austria 19
BE - Belgio 19
TN - Tunisia 15
UZ - Uzbekistan 15
CL - Cile 13
JO - Giordania 13
EG - Egitto 12
EU - Europa 12
TH - Thailandia 12
CZ - Repubblica Ceca 11
KZ - Kazakistan 11
PE - Perù 11
PH - Filippine 11
RS - Serbia 11
SA - Arabia Saudita 11
MY - Malesia 10
PY - Paraguay 10
RO - Romania 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
UY - Uruguay 8
ET - Etiopia 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
SN - Senegal 6
AU - Australia 5
LB - Libano 5
NP - Nepal 5
BH - Bahrain 4
IL - Israele 4
KE - Kenya 4
LT - Lituania 4
AZ - Azerbaigian 3
BG - Bulgaria 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
PR - Porto Rico 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AO - Angola 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
Totale 17.831
Città #
Ashburn 1.149
Singapore 745
Jacksonville 712
Chandler 664
Fairfield 556
Dublin 395
Boardman 376
Dallas 332
New York 315
San Jose 298
Ho Chi Minh City 260
Wilmington 245
Hong Kong 236
Seattle 213
Woodbridge 212
Houston 203
Hanoi 195
Cambridge 182
The Dalles 172
Beijing 152
Lawrence 149
Princeton 149
San Mateo 144
Lauterbourg 142
Los Angeles 132
Ann Arbor 116
Abidjan 99
Moscow 94
Hefei 90
Des Moines 84
Munich 75
San Diego 73
São Paulo 65
Milan 53
Turin 53
London 49
Chicago 45
Ancona 44
Da Nang 44
Buffalo 42
Centro 40
Santa Clara 36
Haiphong 34
Helsinki 34
Turku 34
Council Bluffs 32
Frankfurt am Main 32
Orem 32
Pune 31
Tokyo 31
Miano 28
Warsaw 26
Belo Horizonte 24
Amsterdam 23
Rio de Janeiro 23
Atlanta 21
Montreal 21
Norwalk 21
Washington 21
Brasília 20
Chennai 20
Denver 20
Salt Lake City 20
Hải Dương 19
Brussels 18
Johannesburg 18
Nuremberg 18
Phoenix 17
Baghdad 16
Poplar 16
Stockholm 16
Salvador 15
Brooklyn 14
Guangzhou 14
Mumbai 14
Porto 14
Shanghai 14
Amman 13
Tashkent 13
Toronto 13
Biên Hòa 11
Guayaquil 11
Manchester 11
Mexico City 11
Quảng Ngãi 11
Redmond 11
Rome 11
Vienna 11
Campinas 10
Can Tho 10
Curitiba 10
Lahore 10
Tampa 10
Belgrade 9
Bogotá 9
Cape Town 9
Elk Grove Village 9
Olomouc 9
Porto Alegre 9
Quận Ba 9
Totale 10.441
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 838
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. 241
Assessment of the German and Italian Stress Cardiomyopathy Score for Risk Stratification for In-hospital Complications in Patients with Takotsubo Syndrome 228
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy 182
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 168
Flecainide: Electrophysiological properties, clinical indications, and practical aspects 159
Procedural sedation for direct current cardioversion: a feasibility study between two management strategies in the emergency department 156
Tachycardiomyopathy in Patients without Underlying Structural Heart Disease 153
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 152
An Unusual Left Atrial Mass in a Woman with Active Breast Cancer and Recent Cardiothoracic Surgery 151
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 150
Dronedarone: a real innovation or a mere second-best choice? How to find the way among guidelines, regulatory agencies and daily clinical practice 147
Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers. 146
'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? 146
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 146
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 145
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 144
Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments 138
Amiodarone and digitalis: An odd couple in a tachycardiomyopathic patient 136
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 134
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 134
Comorbidities frequency in takotsubo syndrome: An international collaborative systematic review including 1109 patients 133
Cardioembolism and takotsubo syndrome: A case report 133
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 133
A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I 133
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. 132
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. 131
New anthyarrhythmic drugs for atrial fibrillation 131
Subclinical progression of systemic sclerosis-related cardiomyopathy 128
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. 128
Cardiac resynchronization therapy and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD) 128
Incidence and Clinical Impact of Recurrent Takotsubo Syndrome: Results From the GEIST Registry 127
Dr. Guerra, et al reply 125
Global Longitudinal Strain as a Predictor of First and Subsequent Arrhythmic Events in Remotely Monitored ICD Patients With Structural Heart Disease 125
Coronary Spasm and Inflammation: Can We Kill 2 Birds With 1 Stone? 124
Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD) 123
Takotsubo syndrome in the paediatric population: A case report and a systematic review 123
Letter by Ciliberti and Capucci regarding article, "medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease" 122
Temporal relationship between subclinical atrial fibrillation and embolic events 121
Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE Study. 120
Subclinical atrial fibrillation and the risk of stroke 119
Antiarrhythmic drugs for atrial fibrillation. 119
ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). 118
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. 117
[Early and mid-term results of the transapical aortic valve Symetis Acurate TA: a viable solution in high-risk patients with severe vascular disease] 117
Clinically guided pacemaker choice and setting: pacemaker expert programming study 116
Current Therapeutic Options for Heart Failure in Elderly Patients 116
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 114
Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis 114
Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation 114
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. 114
Atrial Fibrillation and Congestive Heart Failure: should we aim to control the heart's rate or its rhythm? 113
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 113
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry 113
Compassionate drug use for patients with transthyretin amyloid cardiomyopathy 113
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 113
Cardiomyopathy induced by frequent premature ventricular complexes originating from the right ventricular outflow tract: left ventricular systolic function recovery after transcatheter ablation. 112
The ECG in the differential diagnosis between takotsubo cardiomyopathy and acute coronary syndrome 112
Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation 112
IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results 112
Is there an 'atherosclerotic continuum' from angina with unobstructed coronary arteries to MINOCA? 112
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. 111
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. 110
Reproducibility of internal atrial defibrillation threshold in paroxysmal and persistent atrial fibrillation. 108
Transient QRS amplitude attenuation is associated with clinical recovery in patients with takotsubo cardiomyopathy 108
New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. 106
Hospitalization in ICD recipients. 106
Feasibility of a cardiologist-only approach to sedation for electrical cardioversion of atrial fibrillation: A randomized, open-blinded, prospective study 106
Out-of-hospital cardiac arrest and public access defibrillation. 105
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. 105
Capture of atrial fibrillation reduces the atrial defibrillation threshold. 104
The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's. 104
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 104
Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure. 104
Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age 103
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. 102
Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). 102
Community-based automated external defibrillator only resuscitation for out-of-hospital cardiac arrest patients 102
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation 101
Electrical storm and heart failure worsening in implantable cardiac defibrillator patients 101
Efficacy and Safety of Dronedarone in Patients Previously Treated With Other Antiarrhythmic Agents 101
Temporal trends and temperature-related incidence of electrical storm: The TEMPEST Study (Temperature-related incidence of electrical storm) 101
Sedation in cardiac arrhythmias management 101
Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring 101
Indications for implantable cardioverter defibrillator (ICD) therapy. 100
Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis 100
Omega-3 PUFAs and Atrial Fibrillation: Have We Made Up Our Mind Yet? 100
Racial and Ethnic Differences in Electrocardiographic Features of Takotsubo Cardiomyopathy 100
Is invasive coronary provocation testing cost-effective among MINOCA patients? 100
Memorizzazione a distanza dei contenuti teorici derivati dai corsi BLS e BLS-D 100
Endocardial defibrillation lead extraction: an unusual case of entrapment. 99
Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study 99
Entirely Subcutaneous Implantable Defibrillator: Safest Option in a Young Girl With Ventricular Tachycardia and Ebstein Anomaly 99
Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis 98
Rebuttal of critique of Progetto Vita survival data 98
Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs. 98
Symptomatic atrial fibrillation and risk of cardiovascular events: Data from the Euro Heart Survey 97
Emerging pharmacotherapies for the treatment of atrial fibrillation 97
Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study. 96
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: The ALPHEE study 96
Totale 12.790
Categoria #
all - tutte 90.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 0 92
2021/20221.106 89 287 33 25 28 48 73 68 66 71 121 197
2022/20232.113 175 223 146 168 161 281 7 106 469 46 254 77
2023/20241.346 254 48 97 186 233 297 18 36 12 24 15 126
2024/20252.382 191 330 104 18 74 61 128 94 579 167 263 373
2025/20267.099 458 389 385 868 632 442 1.155 703 1.140 526 136 265
Totale 18.076